Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.3c00567 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Weizhi He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Fudan university Shanghai Cancer Center, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Medical Epigenetics, Interna…. Hauptthemen laut MEDLINE: Dioxygenases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ascorbic acid (ASC) has been reported to stimulate DNA iterative oxidase ten-eleven translocation (TET) enzymes, Jumonji C-domain-containing histone demethylases, and potentially RNA m6A demethylases FTO and ALKBH5 as a cofactor. Although ascorbic acid has been widely investigated in reprogramming DNA and histone methylation status in vitro, in cultured cells and mouse models, its specific role in the catalytic cycle of dioxygenases remains enigmatic. Here, we systematically investigated the stimulation of ASC toward TET2, ALKBH3, histone demethylases, and FTO. We find that ASC reprograms epitranscriptome by erasing the hypermethylated m6A sites in mRNA. Biochemistry and electron spin resonance assays demonstrate that ASC enters the active pocket of dioxygenases and reduces Fe(III), either incorporated upon protein synthesis or generated upon rebounding the hydroxyl radical during oxidation, into Fe(II). Finally, we propose a remedied model for the catalytic cycle of dioxygenases by adding in the essential cofactor, ASC, which refreshes and regenerates inactive dioxygenase through recycling Fe(III) into Fe(II) in a dynamic "hit-and-run" manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Institute, Fudan university Shanghai Cancer Center, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry o…
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
ORCID-Profile: Lulu Hu
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
He, W., Yin, X., Xu, C., Liu, X., Huang, Y., Yang, C., Xu, Y., & Hu, L. (2024). Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00567
Vancouver
He W, Yin X, Xu C, Liu X, Huang Y, Yang C, et al. Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00567
BibTeX
@article{He2024,
author = {He, Weizhi and Yin, Xiaotong and Xu, Chu and Liu, Xiangyue and Huang, Yue and Yang, Caiguang and Xu, Yanhui and Hu, Lulu},
title = {Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.3c00567}
}
EUVIMED